Friday, October 12, 2018 01:38 PM

NEW GUIDELINE FOR PROSTATE CANCER SUPPORTS SHORTENED RADIATION THERAPY - IMAGING TECHNOLOGY NEWS (PRESS RELEASE) (BLOG)

October 12, 2018 Three prominent medical societies issued a new clinical guideline for physicians treating men with early-stage prostate cancer[1] using external beam radiation therapy (EBRT)[2]. Adoption of the guideline could make treatment shorter and more convenient for many patients with prostate cancer, the most common malignancy among American men.

Developed by a panel of experts from the American Society for Radiation Oncology (ASTRO), American Society of Clinical Oncology (ASCO) and American Urological Association (AUA), the new guideline recommends offering patients a treatment option known as hypofractionated radiation therapy as an alternative to longer, conventional courses of radiation. ASTRO, ASCO and AUA published the guideline in their respective journals, Practical Radiation Oncology[3], Journal of Clinical Oncology[4] and The Journal of Urology[5].

"Conclusive evidence from several large, well-designed randomized trials now confirms that dose escalation can almost universally benefit men with early-stage prostate cancer who choose to manage ...

News source: GOOGLE NEWS

See also: Associated Urologists Nashville